期刊文献+

以Candin为佐剂的人乳头瘤病毒多肽治疗疫苗刺激朗格汉斯细胞分泌IL-12的研究 被引量:3

Secretion of IL-12 by Langerhans cells stimulated with a human papillomavirus peptide-based therapeutic vaccine containing Candin as an adjuvant
原文传递
导出
摘要 目的探讨佐剂Candin及包含佐剂Candin和HPV多肽的疫苗对朗格汉斯细胞(langerhans cells,LCs)分泌IL-12的影响。方法采用淋巴细胞分离液分离人外周血PBMCs,采用磁珠分选系统分选CD14+细胞,经细胞因子rhGM-CSF(1 000IU/ml)、rhIL-4(1 000IUs)、TGF-β1(10ng/ml)诱导后获得LCs,采用流式细胞术鉴定。用佐剂Candin(50、100、150μl/ml)、包含佐剂Candin(50、100、150μl/ml)和HPV16E6多肽(10μmol/ml)疫苗刺激LCs 24h,ELISA法检测IL-12p70水平。结果诱导培养7d的细胞高表达LCs特征性的表面分子Langerin。佐剂Candin及HPV多肽疫苗均能不同程度刺激LCs分泌IL-12p70。佐剂Candin刺激LCs分泌IL-12p70最高达175ng/ml,HPV多肽疫苗刺激组最高达298ng/ml。含有Candin 100μl/ml的HPV多肽疫苗刺激LCs分泌IL-12p70水平较相应剂量的单独佐剂Candin组高。结论佐剂Candin及HPV多肽疫苗均能刺激LCs分泌IL-12。HPV多肽疫苗刺激LCs分泌IL-12的能力较单独佐剂Candin更强。 Objective To investigate the effect of the adjuvant Candin and a HPV peptide-based therapeutic vaccine containing Candin and HPV peptides on the secretion of IL-12 by Langerhans cells. Methods PBMCs were separated and purified using Ficoll gradient centrifugation and CD14+cells were separated using a CD14 microbead kit.LCs were induced using rhGM-CSF(1,000IU/ml),rhIL-4(1,000IUs),and TGF-β1(10ng/ml),and LCs were identified with FCM.LCs were stimulated with Candin(50,100,and 150μl/ml)and a HPV peptide-based vaccine containing Candin(50,100,150μl/ml)and HPV16E6peptide(10μmol/ml)for 24 h.IL-12p70 secreted by LCs was measured with ELISA. Results The LC-specific molecule langerin was highly expressed in induced cells.IL-12p70 was secreted by LCs stimulated with Candin or the vaccine.IL-12p70 reached 175ng/ml in LCs stimulated with Candin and 298ng/ml in LCs stimulated with the vaccine.More IL-12p70 was secreted by LCs stimulated with the vaccine containing Candin 100μl/ml compared to LCs stimulated with the corresponding amount of Candin. Conclusion Both Candin and the vaccine have the ability to stimulate LCs to secrete IL-12 and the vaccine is better able to stimulate those cells than Candin.
出处 《中国病原生物学杂志》 CSCD 北大核心 2015年第7期587-589,共3页 Journal of Pathogen Biology
基金 国家自然科学基金项目(No.81472439 81101989)
关键词 Candin 人乳头瘤病毒 多肽疫苗 朗格汉斯细胞 白细胞介素12 Candin human papillomaviruss peptide-based vaccine Langerhans cells IL-12
  • 相关文献

参考文献13

  • 1Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types[J]. J Infect Dis, 2002, 185(1)~ 28- 35.
  • 2Walboomers JM, Jacobs MV, Manos MM, et al. Human papillo- mavirus is a necessary cause of invasive cervical cancer worldwide [J]. JPathol, 1999, 189(1): 12 9.
  • 3zur Hausen H. Papillomavirus infections-a major cause of human cancers[J]. BiochimBiophys Acta, 1996, 1288(2): F55-78.
  • 4向华国,曾锦婷,何婉意,黎国.PCR-反向点杂交基因分型与实时荧光定量PCR检测人乳头瘤病毒的研究[J].中国病原生物学杂志,2012,7(5):367-368. 被引量:13
  • 5李耀林,唐双阳,万艳平.人乳头瘤病毒E2蛋白在细胞周期检测点中的作用研究进展[J].中国病原生物学杂志,2012,7(9):713-715. 被引量:2
  • 6余南,辜为为,刘红娥,黄露,徐友红.广州地区人乳头瘤病毒主要基因型及其种系发生分析[J].中国病原生物学杂志,2012,7(11):816-819. 被引量:6
  • 7Farhat S, Nakagawa M, Moscicki AB. Cell-mediated immune re- sponses tohuman papillomavirus 16 E6 and E7 antigens as meas- ured by interferon gammaenzyme-linked immunospot in women with cleared or persistent human papil-lomavirus infection[J]. Int J Gynecol Cancer, 2009, 19(4): 508-12.
  • 8Nakagawa M, Gupta SK, Coleman HN, et al. A {avorable clini- cal trend is associated with CD8 T cell immune responses tothe human papillomavirus type 16 e6 antigens in women being studied forabnormal pap smear results[J]. J Low Genit Tract Dis, 2010, 14(2) : 124-9.
  • 9Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines[J]. Nat Med, 2013, 19(12): 1597-608.
  • 10HogenEsch H. Mechanisms of stimulation of the immune re- sponse by aluminumadjuvants[J]. Vaccine, 2002, 20(3): 34- 9.

二级参考文献36

  • 1蔡虹,关婷,郭利鸿,翁坤荣.人乳头瘤病毒感染的宫颈组织硒的检测及其临床意义[J].中国病原生物学杂志,2006,1(6):410-411. 被引量:4
  • 2蓝春燕,刘继红.人乳头状瘤病毒感染及病毒载量与宫颈病变的相关性研究[J].中华肿瘤防治杂志,2007,14(1):5-8. 被引量:23
  • 3Valdespino VM, Valdespino VE. Cervical cancer screening state of the art[J]. Curr OpinObstet Genecol, 2006, 18(1):35--40.
  • 4Bosch FX, Lorincz A, Munoz N, et al. The causal relation be- tween human papilloma virus and cervical cancer [J]. J Clin Pathol, 2002, 55(4): 244--65.
  • 5Rao PH, Arias Pulido H, Lu XY, et al. Chromosomal amplitica tions, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma[J]. BMC Cancer, 2004, 4: 5--6.
  • 6Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human pap- illoma virus infection: biology, epldemiology, and prevention[J]. Int J Gynecolcancer, 2005, 15(5): 727--46.
  • 7Moody CA,Laimins LA.Human papillomavirus oncoproteins:pathways to transformation[J].Nat Rev Cancer,2010,10(8):550-60.
  • 8Stanley MA,Pett MR,Coleman N.HPV:from infection tocancer[J].Biochem Soc Trans,2007,35(Pt 6):1456-60.
  • 9Blakaj DM,Fernandez-Fuentes N,Chen Z,et al.Evolutionaryand biophysical relationships among the papillomavirus E2pro-teins[J].Front Biosci,2009,14:900-7.
  • 10Thierry F.Transcriptional regulation of the papillomavirus onco-genes by cellular and viral transcription factors in cervical carcino-ma[J].Virology,2009,384(2):375-9.

共引文献18

同被引文献15

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部